Anti-TNF drugs versus long-Term steroid use for patients with inflammatory bowel diseases
Among patients with CD, anti-TNF therapy was also associated with lower rates of Major adverse cardiovascular event (MACE) (OR, 0.68; 95% CI, 0.55-0.85) and hip fracture (OR, 0.54; 95% CI, 0.34-0.83). The risk of serious infection did not differ by treatment for either disease, but the risk of emerg...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
[Washington, D.C.]
Patient-Centered Outcomes Research Institute (PCORI)
2018, [2018]
|
| Series: | Final research report
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references